Please find below a list of Industry Partners and related contributions for the financial year 2015:
Industry1 related income (2015)
|Name of company/funder||Amount of income2||Percentage of overall budget|
|Bayer Pharma||€ 50,000|
|Biogen Idec||€ 370,000|
|GW Pharmaceuticals||€ 6,700|
|Genzyme (Sanofi)||€ 89,000|
|Merck Serono||€ 45,000|
 This should reflect the overall funding received from industry, including, e.g. projects, conferences, etc.
Code of Conduct
On a regular basis, EMSP also collaborates with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Our approach is transparent and rules-based, as set out in our Code of Conduct.
In order to encourage health literacy and sharing of information, EMSP is supporting a number of important industry-funded deliverables. Find a few examples below:
- The State of MS Report – an international survey on improving physician-patient dialogue about multiple sclerosis. A Biogen initiative. Find the 2016 State of MS update report here.